Clinical Trials Browser

Phase 4 × Lung Neoplasms × 90 days × Clear all

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03340506 2026-04-01

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07279935 2026-03-19

REVIVE

Phase 4 Not yet recruiting

100 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

Phase 4 Not yet recruiting

106 enrolled

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT05521789 2026-02-25

Erector Spinae Block for Thoracic Surgery

Phase 4 Recruiting

70 enrolled

Thoracic

Lung Neoplasms, Thoracic Diseases, Thoracic Neoplasms

NCT06105801 2026-02-02

FROSTBITE-3

Phase 4 Recruiting

250 enrolled

Thoracic

Lung Neoplasms

NCT07028593 2026-01-28

CP-MINS

Phase 4 Recruiting

1,058 enrolled

Thoracic

Lung Neoplasms, Thoracic Diseases

Clinical Trials

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Dabrafenib and/or Trametinib Rollover Study

REVIVE

CYTALUX Dose Extension Study

Erector Spinae Block for Thoracic Surgery

FROSTBITE-3

CP-MINS